Post by Life Sciences Ireland

🎙️ New Podcast Episode: Why Ireland Needs a National Life Sciences Cluster This week, I sat down with my colleague Michael O’Neill, whose 30+ years across large pharma, biotech startups, and cluster development—including the early formation of Biocat in Catalonia—give him a unique vantage point on what makes an ecosystem thrive. Michael’s message was clear: clusters don’t form by osmosis. They require intent, investment, coordination, and a long‑term strategic view. He highlighted five proven benefits seen in Catalonia, Cambridge, Denmark and Turku: 🔹 Scalability for startups 🔹 Accelerated innovation 🔹 Shared infrastructure and affordability 🔹 Greater fundability and investor readiness 🔹 Global visibility and identity As Ireland prepares to publish its National Life Sciences Strategy, Michael emphasised the need to: • Map our innovation landscape • Build a unified national identity • Strengthen translation from research to startup • Support patient capital and scale‑up pathways • Balance FDI success with indigenous growth Ireland has world‑class manufacturing. Now we must match it with world‑class innovation. A timely and important conversation for anyone invested in the future of Ireland’s life sciences sector. For more information: 🌐 https://lnkd.in/eudBdcjj 📧 [email protected] ☎️ +353 21 4928944 #LifeSciencesIreland #HealthResearch #Innovation #Strategy #cluster

Video Content